
|Admission Note                                                   |
|THe 73 y/o man is a case of                                      |
|                                                                 |
|1. septic shock with MOF, focus possible psoas muscle abscess    |
|2. prostate ca                                                   |
|                                                                 |
|He was admitted to MICU from ER due to septic shock with MOF.    |
|                                                                 |
|Suggst:                                                          |
|                                                                 |
|-> broadspectrum antibiotic for coverage of IAI and cSSI         |
|-> CRRT for uremic s/s                                           |
|-> correct bleeding tendency                                     |
|-> check adrenal and thyroid function                            |
|-> contact possible next of kin for informing further treatment  |
|plan and grave prognosis                                         |
|2014/11/24 20:11                                                 |
|                                                                 |
|主訴(Chief Complaint)                                            |
|                                                                 |
|Informant:Social worker of our hospital, previous records and the|
|patient's friend General weakness and low back pain since 11/19  |
|                                                                 |
|病史(Brief History)                                              |
|                                                                 |
|This 73-year-old man was admitted to our MICU due to septic      |
|shock. He had a history of 1. Prostate adenocarcinoma, cT3bN1M0, |
|Gleason score 4+5, initial PSA 119.7, under androgen deprivation |
|therapy (2014/11/3-) He lived himself and didn't had family      |
|members. He was independent in his ADLs before this admission,   |
|and he had a work (推拿，至今還有在工作). He was diagnosed of    |
|prostate cancer in 2014/10 with an initial presentation of       |
|hematuria and urinary retention. Androgen deprivation therapy was|
|given since 2014/11/3. About one week before this admission      |
|(11/17), he had an traffic accident. He was sent to 萬芳H, and no|
|obvious fracture was noted. However, low back pain and general   |
|malaise emerged. Due to severe severe low back pain and low limb |
|weakness on 11/19, he was sent to our emergency department on    |
|11/20 for help. On arrival, fever to 38.2°C was noted. CXR showed|
|no obvious infiltration. Blood tests showed marked leukocytosis  |
|(16960), increased CK (30176) and Cre (3.4) with relative low    |
|CK-MB (582). Empirical cefmetazole was given for possible        |
|infection, and hydration was given for rhabdomyolysis. Urologist |
|was consulted on the same day (10/20), and restaging CT scan was |
|suggested. Followed CK gradually decreased but Cre increased on  |
|11/21 (4.2), and nephrologist was consulted. B/C showed          |
|Enterobacter aerogenes (S to Tazocin), and cefmetazole was       |
|changed to Tazocin on 11/22. Renal function kept deteriorating   |
|(11/24 BUN/Cre 168/6.1), and urgent HD was indicated. However,   |
|just after CT scan on 11/24 afternoon, consciousness disturbance,|
|air hunger and hypotension were noted, and he was intubated. CVC |
|was also inserted for levophed and dopamine. The CT image showed |
|enlarged left ileopsoas muscle. He was then admitted to our MICU |
|for further treatment. 【Past History】 (1) Past medical history:|
|prostate cancer (2) Past surgical history: 2014_10_14 1.         |
|Transrectal ultrasonography-guided biopsy of the prostate 2.     |
|Cystoscope (3) Hospitalization history: 入院日期:2014_10_09 出院 |
|日期:2014_10_17 診斷:Elevated prostate specific antigen (4)      |
|Allergy: NKA Medication ADR: unknown Allergy to Medical Device   |
|and Materials: unknown (5) Cigarette smoking: quitted for 13     |
|years, Alcohol: quitted for 23 years, Betel nut: denied (6) Blood|
|type:O (7) TOCC: travel(-), occupation: nil, contact(-),         |
|cluster(-) 【Current Medication】 Rolikan 16.6 mEq/20 mL /amp    |
|66.4 mEq QD IF 3 days Calglon (10%) 4.65 mEq/10 mL /amp 4.65 mEq |
|QD IF 3 days TAZOCIN (based on piperacillin content) 2000 mg/vial|
|2000 mg Q8H IF 3 days 警 Humulin R 1000 U/10 mL /vial 12 U TIDAC |
|SC 2 days 警 Humulin N (NPH) 1000 U/10 mL /vial 8 U HS SC 2 days |
|Rasitol Inj 20 mg/2 mL /amp 20 mg STAT IV 1 days Rasitol Inj 20  |
|mg/2 mL /amp 20 mg Q8H IV 2 days 警 Humulin R 1000 U/10 mL /vial |
|10 U STAT SC 1 days Rasitol Inj 20 mg/2 mL /amp 20 mg STAT IV 1  |
|days Gascon 40 mg/tab 1 tab TIDPC PO 2 days Burinex 1 mg/tab 1   |
|tab STAT PO 1 days Primperan Inj 10 mg/2 mL /amp 10 mg QD IV 2   |
|days Midorine 2.5 mg/tab 2 tab ONCE PO 1 days 警 Dopamine HCl,   |
|Baxter 400 mg/250 mL /bag 400 mg QD cIF 2 days 警 Dopamine HCl,  |
|Baxter 400 mg/250 mL /bag 400 mg QD cIF 2 days 警 Dopamine HCl,  |
|Baxter 400 mg/250 mL /bag 400 mg QD cIF 2 days 警 Levophed 4 mg/4|
|mL /amp 16 mg QD cIF(CVC) 2 days 警 Levophed 4 mg/4 mL /amp 16 mg|
|QD cIF 2 days Diphenhydramine HCl 30 mg/1 mL /amp 30 mg STAT IF 1|
|days 瓶 Rolikan 7% 250 mL/btl 1 btl STAT IF(CVC) 1 days Androcur |
|50 mg/tab 1 tab BID PO 28 days Bethanechol 25 mg/tab 1 tab BID PO|
|28 days 中草藥: nil 保健食品: nil 【Family History】 no known    |
|family history                                                   |
|                                                                 |
|社會心理相關評估(Psychosocial Assessment)                        |
|                                                                 |
|Social Economic and Personal History 教育程度:小學 職業:其他     |
|宗教信仰:無 婚姻狀態:未婚 使用語言:國語 台語 口述血型:O，RH:不清 |
|楚，輸血反應: 抽煙:沒有，已戒煙:13年 喝酒:沒有，已戒酒:23年      |
|檳榔:沒有 物質濫用:不知道 Psychological History and Evaluation   |
|意識狀態:木僵 認知功能:無法評估 精神情緒狀態:異常 其他 意識木僵~ |
|躁動 安全問題:有 其他 預防跌倒及管路安全(雙手約束帶) 睡眠形態:異 |
|常 其他 意識木僵~躁動 Nutritional Screen 攝食情形: 排便狀態:異常 |
|排便異常狀態:其他 其他排便異常狀態:tarry stool BMI:25.11 Fall    |
|Risk Assessment 總分:16 (>=3分進行不倒翁計畫，請開預防跌倒醫囑)  |
|                                                                 |
|系統性回顧(Review of System)                                     |
|                                                                 |
|(■:positive, □:negative) 1.Systemic: ■fever: 11/20, □chills,     |
|□night sweats, ■fatigue: since 11/19, □somnolence, □insomnia     |
|□weight change, □decreased appetite, □consciousness disturbance, |
|□diffuse arthralgias/myalgias, □heat/cold intolerance, □thirsty, |
|□general edema 2.Head/Eyes: □headache, □dizziness, □vertigo,     |
|□photophobia, □diplopia, □visual field defect, □blurred vision,  |
|□ocular pain, □eye redness, □dry eye, □excess tearing □alopecia, |
|□head trauma, □cataracts, □glaucoma 4.Ears/Nose: □hearing        |
|impairment, □tinnitus, □otalgia, □otorrhea, □nasal congestion,   |
|□rhinorrhea, □epistaxis, □anosmia 5.Mouth/Throat: □oral ulcer,   |
|□gum bleeding, □dry mouth, □dental problems □sore throat,        |
|□dysphagia, □odynophagia, □hoarseness 6.Cardiovascular/ □cough,  |
|□sputum, □hemoptysis, □wheezes Respiratory: □dyspnea:at          |
|rest/exertional, □chest tightness/pain: with diaphoresis,        |
|□orthopnea, □paroxysmal nocturnal dyspnea, □syncope,             |
|□palpitation, □intermittent claudication 7.Gastrointestinal:     |
|□anorexia, □nausea, □vomiting:bilious/feculent, □hematemesis     |
|□heartburn/acid regurgitation, □belching, □hiccup □abdominal     |
|pain:______, □abdominal distention □diarrhea, □constipation,     |
|□tarry stool, □clay-colored stool □change of bowel habit,        |
|□tenesmus, □flatulence 8.Genito-urinary: □urinary frequency,     |
|□urgency, □dysuria, □incontinence, □nocturia, □polyuria,         |
|□oliguria □small stream of urine, □hesitancy, □cloudy urine,     |
|□hematuria, □flank pain, □impotence, □abnormal sexual exposure   |
|9.Gynecological: □abnormal menstruation 10.Skin/ □rash,          |
|□pruritus, □dryness, □jaundice, □color changes, Hemagological:   |
|□moles, □plaque, □ulcers, □hair loss, □hirsutism,                |
|□telangiectasia, □petechiae, □ecchymoses, □purpura               |
|11.Musculoskeletal: □arthralgia, □myalgia, ■back pain: after     |
|11/17, □bone pain, □joint stiffness, □cramps, □fractures         |
|12.Neurological: □numbness, □paresis/plegia, □convulsion,        |
|□paresthesia, □allodynia □resting tremor, □gait disturbance,     |
|13.Psychiatric: □insomnia, □memory loss, □anxiety, □panic        |
|□hallucination, □delusion, □depression, □suicidality             |
|                                                                 |
|身體檢查(Physical Examination)                                   |
|                                                                 |
|BH:166 cm BW:69.2 kg T:36.3 P:116 R:26 BP:72/39 mmHg Pain:0      |
|Neurological Examination: . Consciousness:agitated . Muscle      |
|power:not evaluated . Gait:not evaluated 1. General appearance:  |
|ill-looking 2. Consciousness: agitated, Activity: lying in bed 3.|
|HEENT: gross anomaly(-); Conjunctiva: not pale; Sclera:          |
|anicteric; Pupils: isocoric 3mm/3mm, Light reflex: +/+, prompt;  |
|Throat: injected(-); ulcer(-); Neck: supple, LAP(-), goiter(-) 4.|
|Chest: symmetric expansion, no retraction breath sounds: coarse, |
|wheezes(-), rhonchi(-), rales(-) 5. Heart: RHB, PMI at 5ICS of   |
|LMCL, no heave or thrill Normal S1, S2. No S3, S4, or murmurs 6. |
|Abdomen: soft, normoactive bowel sound tenderness(-), rebound    |
|tenderness(-) liver/spleen: impalpable 7. Extremity: cyanosis(+),|
|pitting edema: bilateral leg 2+ 8. Skin: rash(-), jaundice(-),   |
|petechiae(-), ecchymosis(-)                                      |
|                                                                 |
|檢驗紀錄(Laboratory Report)                                      |
|                                                                 |
|*********檢驗室:RL*********** 群組:Blood pH/Gas PH PCO2 PO2 HCO3 |
|BaseExcess time/item (*) (mmHg) (mmHg) (mmol/L) (mmol/L) 1031124 |
|[1635] 7.399 23.6 165.1 14.7 -10.4 群組:CBC+PLT WBC RBC HB HCT   |
|MCV time/item (K/μL) (M/μL) (g/dL) (%) (fL) 1031124 [1635] 36.56 |
|2.56 7.7 21.0 82.0 MCH MCHC PLT RDW-CV PS time/item (pg) (g/dL)  |
|(K/μL) (%) () 1031124 [1635] 30.1 36.7 61 15.0 -                 |
|*********檢驗室:RL*********** 群組:Blood pH/Gas PH PCO2 PO2 HCO3 |
|BaseExcess time/item (*) (mmHg) (mmHg) (mmol/L) (mmol/L) 1031120 |
|[1212] 7.338 37.7 28.4 20.4 -5.6 1031122 [0449] 7.364 35.4 32.5  |
|20.4 -5.3 1031123 [0423] 7.374 29.6 37.8 17.4 -8.1 1031123 [2359]|
|7.408 29.3 47.0 18.7 -6.3 1031124 [0432] 7.350 35.0 38.9 19.5    |
|-6.4 群組:Biochemistry BUN CRE Na K Ammonia N time/item (mg/dL)  |
|(mg/dL) (mmol/L) (mmol/L) (μmol/L) 1031120 [1212] 3.4 118 5.5 22 |
|1031120 [1636] 1031120 [2243] 128 1031121 [0609] 104.4 4.2 125   |
|5.0 1031121 [1228] 1031122 [0449] 119.4 5.4 125 4.6 1031122      |
|[0623] 1031122 [0751] 1031123 [0423] 145.6 5.9 127 3.9 1031123   |
|[2359] 163.6 6.3 131 3.9 1031124 [0432] 168.0 6.1 129 4.2 1031124|
|[1158] 181.0 6.3 129 4.7 110 1031124 [1215] 150.1 6.2 129 4.8 63 |
|1031124 [1416] T-BIL Ca Mg P AST time/item (mg/dL) (mmol/L)      |
|(mmol/L) (mg/dL) (U/L) 1031120 [1212] 1031120 [1636] 0.74 487    |
|1031120 [2243] 1031121 [0609] 1031121 [1228] 1.84 1031122 [0449] |
|1031122 [0623] 1.64 1031122 [0751] 4.8 1031123 [0423] 1.69       |
|1031123 [2359] 1031124 [0432] 1031124 [1158] 1.64 1.16 1031124   |
|[1215] 1.65 1.09 1031124 [1416] LacticAcid CK CK-MB %CKMB        |
|Troponin I time/item (mmol/L) (U/L) (U/L) (%) (ng/mL) 1031120    |
|[1212] 30127 1031120 [1636] 30176 582 1.9 0.128 1031120 [2243]   |
|22979 0.118 1031121 [0609] 17637 1031121 [1228] 1031122 [0449]   |
|10778 1031122 [0623] 1031122 [0751] 1031123 [0423] 5969 1031123  |
|[2359] 3592 1031124 [0432] 3244 1031124 [1158] 7.32 3232 76 2.4  |
|0.055 1031124 [1215] 6.54 3329 77 2.3 0.055 1031124 [1416] 9.17  |
|群組:Yes Blood Ketone pro-BNP time/item (mmole/L) (pg/mL) 1031120|
|[1222] 0.8 1031120 [1636] 3950 1031124 [1158] 3550 1031124 [1215]|
|3600 群組: BUN(U) CRE(U) Mucus(S) time/item () (mg/dL) (*)       |
|1031120 [1250] - 1031121 [2043] 354.1 113 1031124 [1224] -       |
|群組:General BioChemistry ALB D-BIL ALT ALP time/item (g/dL)     |
|(mg/dL) (U/L) (U/L) 1031120 [1212] 227 1031120 [1636] 0.20 186   |
|1031121 [1228] 2.3 1031124 [1158] <1.5 95 群組:SEDIMENT RBC(S)   |
|WBC(S) EpithCell(S) Cast(S) Crystal(S) time/item (/HPF) (/HPF)   |
|(/HPF) (/LPF) (*) 1031120 [1250] >100 >100 0-2 - - 1031124 [1224]|
|35-50 >100 2-5 - - Others(S) Bacteria time/item (*) (*) 1031120  |
|[1250] - 4+ 1031124 [1224] Yeast(3+) 3+ 群組:MULTISTIX Sp. Gr.(C)|
|pH(C) Protein(C) Glu.(C) Ketones(C) time/item (*) (*) (mg/dL)    |
|(mg/dL) (*) 1031120 [1250] 1.009 6.5 70 ( 1+ ) >1000 ( 4+ ) +/-  |
|1031124 [1224] 1.012 5.0 50 ( 1+ ) - - O.B.(C) Urobil.(C) Bil.(C)|
|Nitrite(C) WBC(C) time/item (mg/dL) (mg/dL) (mg/dL) (*) (*)      |
|1031120 [1250] 3+ ≦1.5 - - 3+ 1031124 [1224] 3+ ≦1.5 - - 3+ Color|
|Turbidity time/item (*) (*) 1031120 [1250] Light Orange 2+       |
|1031124 [1224] Light Orange 2+ 群組:WBC Classification Blast     |
|Promyl. Myelo. Meta Band time/item (%) (%) (%) (%) (%) 1031120   |
|[1212] 0.0 0.0 0.0 2.9 20.0 1031121 [0609] 0.0 0.0 0.0 0.0 6.0   |
|1031124 [1215] 0.0 0.0 0.0 0.0 7.0 1031124 [1224] 0.0 0.0 1.0 0.5|
|8.5 Seg Eos. Baso. Mono. Lym. time/item (%) (%) (%) (%) (%)      |
|1031120 [1212] 70.5 0.0 0.0 3.8 2.8 1031121 [0609] 83.0 0.0 0.0  |
|6.0 5.0 1031124 [1215] 87.0 0.0 0.0 4.0 2.0 1031124 [1224] 82.0  |
|0.0 0.0 4.0 2.5 Aty.Lym. PlasmaCell Normobl. PS time/item (%) (%)|
|() () 1031120 [1212] 0.0 0.0 1.0 /100 WBC WBC 100 1031121 [0609] |
|0.0 0.0 0.0 /100 WBC WBC 100 1031124 [1215] 0.0 0.0 0.0 /100 WBC |
|WBC 100 1031124 [1224] 1.5 0.0 1 /200 WBC WBC 200 群組:CBC+PLT   |
|WBC RBC HB HCT MCV time/item (K/μL) (M/μL) (g/dL) (%) (fL)       |
|1031120 [1212] 16.96 3.92 12.1 33.0 84.2 1031121 [0609] 18.11    |
|3.54 10.5 29.4 83.1 1031124 [1215] 33.45 2.20 6.4 18.2 82.7      |
|1031124 [1224] 32.38 2.30 7.0 19.0 82.6 MCH MCHC PLT RDW-CV PS   |
|time/item (pg) (g/dL) (K/μL) (%) () 1031120 [1212] 30.9 36.7 99 ?|
|PLT cl 14.1 - umps 1031121 [0609] 29.7 35.7 67 ? PLT cl 14.0 -   |
|umps 1031124 [1215] 29.1 35.2 40 14.9 - 1031124 [1224] 30.4 36.8 |
|53 (Manual c 15.2 - hecked) *********檢驗室:PO*********** 群組:  |
|Sugar(One to uch) time/item (*) 1031120 [1213] 486 1031120 [1728]|
|109 1031120 [2242] 151 1031121 [0637] 259 1031121 [1753] 305     |
|1031122 [0449] 398 1031122 [1053] 417 1031122 [1727] 284 1031123 |
|[0419] 385 1031123 [1010] 398 1031123 [1720] 242 1031123 [2014]  |
|200 1031124 [0432] 325 1031124 [1103] 376 1031124 [1223] 351     |
|*********檢驗室:SA*********** 群組:Yes S.T.S. (VDRL /RPR Test)   |
|time/item (*) 1031124 [1215] Non-Reactive                        |
|*********檢驗室:VH*********** 群組: HIV Ag/Ab Co mbo -for scr    |
|eening test time/item (*) 1031124 [1215] Negative                |
|*********檢驗室:M6*********** 群組:Yes Bacteria Bilirubin Blood  |
|Cast Crystals time/item (*) (*) (*) (*) (*) 1031121 [2043]       |
|Negative Negative ( +++ ) ( + )-Granul 0 ar Epi Cell/HPF Glucose |
|Ketone Others PH time/item (/HPF) (*) (*) (*) (*) 1031121 [2043] |
|3-5 Negative Negative Microscopic 6.0 hematuria, s /p Pyuria     |
|Protein RBC(morpholo RBC/HPF Urobilinogen WBC/HPF gy) time/item  |
|(*) (*) (/HPF) (*) (/HPF) 1031121 [2043] ( ++ )-100 m Negative   |
|5-8 Normal Numerous g/dl *********檢驗室:B2***********           |
|B2-1031120-0058071 BLOOD ID+DS Blood.#1: Enterobacter aerogenes  |
|B2-1031120-0058070 BLOOD ID+DS Blood.#1: Enterobacter aerogenes  |
|*********檢驗室:YM*********** 群組: Free Ca(急重症自 Hb(急重症自 |
|行檢驗) Hct(急重症自行檢驗) K+(急重症自行檢驗) Na(急重症自行檢驗)|
|行檢驗) time/item (mmol/L) (g/dL) (%) (mmol/L) (mmol/L) 1031124  |
|[1139] 1.08 7.3 22 4.62 124.4 1031124 [1411] 1.10 8.7 26 5.19    |
|126.0 Suger(急重症自行檢 LacticAcid(急 驗) 重症自行檢驗)         |
|time/item (mg/dL) (mmol/L) 1031124 [1139] 407 6.3 1031124 [1411] |
|376 9.5 群組:Yes pH pCO2 pO2 HCO3 BaseExcess time/item () (mmHg) |
|(mmHg) (mmol/L) (mmol/L) 1031124 [1139] 7.346 24.6 150.3 13.6    |
|-12.3 1031124 [1411] 7.131 30.2 56.8 10.2 -19.2 SO2 time/item (%)|
|1031124 [1139] 99.3 1031124 [1411] 79.8                          |
|*********檢驗室:BK*********** 群組:Yes antibody scr een(New Lis) |
|time/item (*) 1031124 [1416] Negative 群組:Blood Type ABO Typing |
|RH Typing time/item (*) (*) 1031124 [1416] O Positive            |
|                                                                 |
|檢查紀錄(Examination Report)                                     |
|                                                                 |
|nil                                                              |
|                                                                 |
|影像報告(Imaging Report)                                         |
|                                                                 |
|CT Without Contrast-Chest 醫令: CT Without Contrast-Chest 報告醫 |
|師: 曾堯暉 影像時間: 2014/11/24 13:30 (33070B2M) 發報告時間:     |
|2014/11/24 14:25 CT of chest without contrast enhancement shows: |
|- Lungs: pulmonary emphysema. Partial atelectasis of bilateral   |
|lower lobes. - Pleura: bilateral mild effusion. - Thoracic lymph |
|nodes: no lymphadenopathy. - Bones: spondylosis with marginal    |
|spurs. - Chest wall and lower neck: normal. - Other: placement of|
|a central venous catheter. CT Without Contrast-Brain 醫令: CT    |
|Without Contrast-Brain 報告醫師: 陳雅芳 影像時間: 2014/11/24     |
|13:30 (33070B0M) 發報告時間: 2014/11/24 14:04 Brain CT without   |
|contrast enhancement shows: 1. Suboptimal study due to motion    |
|artifacts. 2. Brain atrophy with dilated sulci, fissures and     |
|ventricles. 3. Mild nonspecific low density change at bilateral  |
|periventricular white matter 4. No intracranial hemorrhage noted.|
|4. No obvious abnormality at cranial vault and skull base. 5.    |
|Right mastoid effusion CT Without Contrast-Pelvis 醫令: CT       |
|Without Contrast-Pelvis 報告醫師: 劉高郎 影像時間: 2014/11/24    |
|13:30 (33070B5M) 發報告時間: 2014/11/24 15:29 History of 74M;    |
|prostate cancer, advanced, T3bN1M0; undergoing androgen          |
|deprivation therapy at NUTH; Study: abdominal and pelvis CT,     |
|without contrast enhancement Indication: for sepsis Findings:    |
|(about the head and chest regions, please see the head and chest |
|CT reports) 1. A foley catheter insertion is noted. Diffuse wall |
|thickening of the urinary bladder is noted. 2. there is no       |
|evidence of paraaortic LAPs in abdomen; there is no evidence of  |
|LAPs in pelvic cavity and bilateral inguinal areas. 3. there is  |
|no ascites 4. small gall stones; no definite radiopaque stones in|
|the CBD; The bile ducts and P duct are not dilated. 5. enlarged  |
|left ileopsoas muscle; pyomyosititis can not be excluded. Suggest|
|clinical correlation 6. spondylosis of the lumbar spine is noted;|
|diffuse disc space narrowing; CT Without Contrast-Abdomen 醫令:  |
|CT Without Contrast-Abdomen 報告醫師: 劉高郎 影像時間: 2014/11/24|
|13:30 (33070B3M) 發報告時間: 2014/11/24 15:29 History of 74M;    |
|prostate cancer, advanced, T3bN1M0; undergoing androgen          |
|deprivation therapy at NUTH; Study: abdominal and pelvis CT,     |
|without contrast enhancement Indication: for sepsis Findings:    |
|(about the head and chest regions, please see the head and chest |
|CT reports) 1. A foley catheter insertion is noted. Diffuse wall |
|thickening of the urinary bladder is noted. 2. there is no       |
|evidence of paraaortic LAPs in abdomen; there is no evidence of  |
|LAPs in pelvic cavity and bilateral inguinal areas. 3. there is  |
|no ascites 4. small gall stones; no definite radiopaque stones in|
|the CBD; The bile ducts and P duct are not dilated. 5. enlarged  |
|left ileopsoas muscle; pyomyosititis can not be excluded. Suggest|
|clinical correlation 6. spondylosis of the lumbar spine is noted;|
|diffuse disc space narrowing; Abdomen:KUB 醫令: Abdomen:KUB 報告 |
|醫師: 王甄 影像時間: 2014/11/23 14:41 (32006C0M) 發報告時間:     |
|2014/11/23 15:32 stool impaction. distened bowels at whole       |
|abdomen. DJD change of L spine. radiopaque densities at pelvis.  |
|Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師:|
|王甄 影像時間: 2014/11/23 05:22 (32001CYM) 發報告時間: 2014/11/23|
|11:28 normal heart size. tortuous aorta. TL scoliosis.           |
|subsegmental atelectasis at LLL. Suggest clinical correlation and|
|follow-up. Spine: Thoracic AP, LAT. 醫令: Spine: Thoracic AP,    |
|LAT. 報告醫師: 許昭禹 影像時間: 2014/11/20 13:19 (000MP086) 發報 |
|告時間: 2014/11/20 13:40 osteopenia of the visible bony          |
|structures. kyphoscoliosis of the thoracic spine. thoracic       |
|spondylosis with marginal spur formation at multiple levels.     |
|However, small osseous or soft tissue lesion(s) may not be       |
|detected by the plain radiography. Advise correlate with other   |
|imaging study, if clinically indicated. Spine: Lumbosacral AP,   |
|LAT. 醫令: Spine: Lumbosacral AP, LAT. 報告醫師: 許昭禹 影像時間:|
|2014/11/20 13:19 (000MP090) 發報告時間: 2014/11/20 13:35         |
|osteopenia of the visible bony structures. scoliosis of the      |
|spine, probably due to positioning factor. lumbar spondylosis    |
|with disc space narrowing, intradiscal vacuum phenomenon and     |
|marginal spur formation at the L3-4, L4-5 and L5-S1 levels. bil. |
|facet arthroses at the lower lumbar levels. atherosclerotic      |
|change of the abdominal aorta and its bifurcation. essential     |
|intact sacroiliac joints on both sides. However, small osseous or|
|soft tissue lesion(s) may not be detected by the plain           |
|radiography. Advise correlate with other imaging study, if       |
|clinically indicated. Chest : AP View (Supine) 醫令: Chest : AP  |
|View (Supine) 報告醫師: 王甄 影像時間: 2014/11/20 13:18          |
|(32001CYM) 發報告時間: 2014/11/20 14:04 borderline heart size,   |
|tortuous aorta. aortic wall calcification. TL scoliosis. no      |
|active lung lesions. Lower Leg Both 醫令: Lower Leg Both         |
|報告醫師: 許昭禹 影像時間: 2014/11/20 14:32 (000MP031)           |
|發報告時間: 2014/11/20 15:03 osteopenia of the visible bony      |
|structures. traction enthesophyte formation over the bil.        |
|patellar bases. no evidence of fracture or dislocation. However, |
|small osseous or soft tissue lesion(s) may not be detected by the|
|plain radiography. Advise correlate with other imaging study, if |
|clinically indicated. Femur Both 醫令: Femur Both 報告醫師: 許昭 |
|禹 影像時間: 2014/11/20 14:31 (000MP037) 發報告時間: 2014/11/20  |
|15:03 osteopenia of the visible bony structures. traction        |
|enthesophyte formation over the bil. patellar bases. no evidence |
|of fracture or dislocation. However, small osseous or soft tissue|
|lesion(s) may not be detected by the plain radiography. Advise   |
|correlate with other imaging study, if clinically indicated.     |
|                                                                 |
|病理報告(Pathology Report)                                       |
|                                                                 |
|S1440814 Prostate,right lateral,transrectal ultrasound-guided    |
|biopsy,adenocarcinoma Gleason score 4+5=9, Prostate,right        |
|medial,transrectal ultrasound-guided biopsy,adenocarcinoma       |
|Gleason score 4+5=9, Prostate,left medial,transrectal            |
|ultrasound-guided biopsy,adenocarcinoma Gleason score 4+4=8,     |
|Prostate,left lateral,transrectal ultrasound-guided              |
|biopsy,adenocarcinoma Gleason score 4+5=9,                       |
|                                                                 |
|臆斷(Tentative Diagnosis)                                        |
|                                                                 |
|1. Septic shock 2. Rhabdomyolysis, suspected left psoas abscess  |
|related 3. Enterobacter aerogenes bacteremia 4. Acute kidney     |
|injury, RIFLE "F", probable rhabdomyolysis or sepsis related 5.  |
|Prostate adenocarcinoma, cT3bN1M0, Gleason score 4+5, initial PSA|
|119.7, under androgen deprivation therapy (2014/11/3-) 6. History|
|of urinary tract infection in 2014/10, prostate cancer related   |
|                                                                 |
|醫療需求與治療計畫(Medical Needs and Care Plan)                  |
|                                                                 |
|#Septic shock #Rhabdomyolysis with AKI #Enterobacter aerogenes   |
|bacteremia #Prostate cancer A: prostated cancer diagnosed in     |
|2014/10 2014/11/17 traffic accident, 萬芳H: no fracture          |
|2014/11/19 severe severe low back pain and low limb weakness     |
|2014/11/20 NTUH ED: BT 38.2°C WBC 16960, myel~seg 2.9, 20, 70.5  |
|CK/CK-MB 30176/582 TnI 0.128, Cre 3.4 ==> on cefmetazole B/C:    |
|Enterobacter aerogenes (S to Tazocin) ==> change to Tazocin 11/24|
|BUN/Cre 168/6.1 septic shock with consciousness change ABG       |
|7.131/30.2/56.8/10.2/-19.2 ==> 3C2 admission difficult A-Line, on|
|one-way A-line prepare for CVVH Hb 7.7, give pRBC 2U P: change   |
|Tazocin to Maxipime+Anegyn for better coverage of AmpC and       |
|anaerobics start CVVH for severe uremia contact family and inform|
|poor prognosis if possible (he came with only a friend)          |
|[Treatment Goal] 1. Infection control, complete antibiotics      |
|treatment 2. Recovery of AKI or beginning of long-term HD        |
|                                                                 |
|出院規劃(Discharge Planning)                                     |
|                                                                 |
|管路留置狀況:有 靜脈管路留置(含Hickman / Port-A)：有 左頸 右足   |
|雙腔導管留置：無 鼻胃管留置：無 氣管管路留置：有 氣管內管 7.5mm  |
|胃造廔口：無 尿管留置：有 Three way Foley 18Fr. 膀胱造廔：無     |
|傷口引流管：無 其他導管： 日常生活功能分數：0 預期出院後居住場所 |
|：獨居 預期出院後主要照顧者：自己 出院規劃收案篩檢：高危病患     |
|獨居老人 帶有管路 功能量表未滿60分                               |
|                                                                 |
|主治醫師評論(VS Comments)                                        |
|                                                                 |
|I agree with the assessment of the resident.                     |
|                                                                 |
|醫師姓名                                                         |
|                                                                 |
|古世基 主治醫師                                                  |
|                                                                 |

